Recent studies have revealed that GnRH‐a medication might significantly decrease inflammatory reactions and angiogenic responses and generate a surprisingly high degree of apoptosis in women with endometriosis, in addition to its hypoestrogenic effects.28 Here, GNRH1 is linked to endometriosis.